A recent study conducted in cholangiocarcinoma cells showed that overexpression of RPS6 is associated with tumour cell proliferation and silencing of RPS6 results in cell cycle arrest and reduced tumorigenicity [102]. The gene discussed is RPS6; the disease is neoplasm.